Peptides are naturally occurring biological molecules that play a prominent role in important biological activities. Extensive efforts have been taken in pharmaceutical research and development (R&D) to develop new peptides for the treatment of chronic conditions. Over 7000 naturally occurring peptides have been identified in recent years, which function as neurotransmitters, hormones, ion channel ligands, and growth factors, amongst others to facilitate various human physiologies. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptide therapeutics market growth.
Increasing utilization
of peptide molecules for the development of COVID-19 vaccine is estimated to
have a positive impact on the market growth. Moreover, extensive support from
government authorities for the use of peptides for COVID-19 vaccine development
is also anticipated to offer potential opportunity for the adoption of
peptides, which will eventually accelerate the growth of peptide therapeutics
market.
Sample PDF showcases the content structure and
the nature of the information included in the report which presents a
qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00003793/
Leading Peptide Therapeutics Market Players:
- Eli Lilly
and Company
- Amgen Inc.
- TEVA
PHARMACEUTICAL INDUSTRIES LTD
- Polypeptide
Group
- EVER Pharma
GmbH
- Bristol-Myers
Squibb Company
- Novo Nordisk
A/S
- Sanofi
- AstraZeneca
PLC
- Glaxosmithkline
PLC
Segmentation:
On
the basis of type, the peptide therapeutics market is segmented into innovative
and generic. The innovative segment held a larger share of the market in 2019;
however, the generic segment is expected to register a higher CAGR during the
forecast period. Rising number of research collaborations amongst market
players are estimated to offer favorable environment for growth of generic
segment.
Increasing prevalence of metabolic and infectious
diseases is one of the prominent factors expected to drive the peptide
therapeutics market. For instance, according to a data published by the Centers
of Disease Control and Prevention (CDC) in 2020, an estimated 34.2 million
people in the US were suffering from diabetes. In addition, according to the
same studies, the prevalence of diabetes is continually increasing as compared
to the past decades. In addition, according to a study published by the CDC in
2020, approximately 400 babies are diagnosed with hemophilia each year in the
US. Further, according to a study published by the NIH in 2019, sickle cell
anemia affects around 100,000 people in the US and one million people across
the globe each year.
Our reports will help clients solve the following issues: –
Insecurity about the future:
Our research and insights help our clients
anticipate upcoming revenue compartments and growth ranges. This will help our
clients invest or divest their assets.
Understanding market opinions:
It is extremely vital to have an impartial understanding
of market opinions for a strategy. Our insights provide a keen view on the
market sentiment. We keep this reconnaissance by engaging with Key Opinion
Leaders of a value chain of each industry we track.
Understanding the most reliable investment centers:
Our research ranks investment centers of market by
considering their future demands, returns, and profit margins. Our clients can
focus on most prominent investment centers by procuring our market research.
Evaluating potential business partners:
Our research and insights help our clients identify
compatible business partners.
Immediate delivery of our off-the-shelf reports and pre booking of upcoming studies, through flexible and convenient payment methods – https://www.theinsightpartners.com/sample/TIPRE00003793/
Peptide Therapeutics Market Segmented by Region/Country: North
America, Europe, Asia Pacific, Middle East & Africa, and Central &
South America
About Us:
The Insight Partners is a one stop industry research
provider of actionable intelligence. We help our clients in getting solutions
to their research requirements through our syndicated and consulting research
services. We specialize in industries such as Semiconductor and Electronics,
Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare
IT, Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you
would like further information, please
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Comments
Post a Comment